Drug Search Results
More Filters [+]

Azlocillin

Alternative Names: azlocillin, azlin
Latest Update: 2021-04-20
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Cell Wall Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Approved

Approved Countries: Bulgaria | Germany | India | Ireland | Italy | New Zealand | Taiwan

Approved Indications: None

Known Adverse Events: None

Company: Shandong University
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Azlocillin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2019_EOS_001

N/A

Recruiting

Neonatal Sepsis

2025-10-01

Recent News Events

Date

Type

Title